Elizabeth Glynn Nilson, MD | |
67 S Bedford St Ste 202e, Burlington, MA 01803-5141 | |
(781) 744-7000 | |
(781) 744-7516 |
Full Name | Elizabeth Glynn Nilson |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 67 S Bedford St Ste 202e, Burlington, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639112022 | NPI | - | NPPES |
110082094A | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 238648 (Massachusetts) | Secondary |
207R00000X | Internal Medicine | 238648 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lahey Health At Home | Beverly, MA | Home health agency |
Elara Caring | Byfield, MA | Home health agency |
Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
Winchester Hospital | Winchester, MA | Hospital |
Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
Northeast Hospital Corporation | Beverly, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lahey Clinic Inc | 2264336528 | 1211 |
News Archive
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.
What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.
NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
› Verified 6 days ago
Entity Name | Lahey Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.
What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.
NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
› Verified 6 days ago
Entity Name | Lahey Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.
What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.
NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Elizabeth Glynn Nilson, MD 41 Mall Rd, Lahey Clinic, Burlington, MA 01805-0001 Ph: (781) 744-7000 | Elizabeth Glynn Nilson, MD 67 S Bedford St Ste 202e, Burlington, MA 01803-5141 Ph: (781) 744-7000 |
News Archive
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.
What changes in the brain are caused by Alzheimer's disease? How do these changes differ from those observed in the normal aging process? Researchers from the CNRS, the école pratique des hautes études and the University of Valencia explored these questions by analyzing over 4,000 MRI scans of healthy and diseased brains using the "volBrain" platform.
NanoViricides, Inc. reported dramatically improved antiviral efficacy with its optimized FluCide™ drug candidates in its most recent animal study.
Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.
› Verified 6 days ago
Joseph Dubin, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd., Lahey Clinic, Burlington, MA 01805 Phone: 781-744-7000 Fax: 781-744-5378 | |
Gerard Daly, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-5700 Fax: 781-744-5358 | |
Sahoor Khan, Internal Medicine Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Kristen M Robson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8699 Fax: 781-744-5276 | |
Eric Scott Kerns, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Lahey Hospital & Medical Center, Burlington, MA 01805 Phone: 781-744-8430 Fax: 781-744-5397 | |
Neethi Rebekah Dasu, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 | |
Frederick W Heiss, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-5100 |